United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 2008 NY Rulings > NY N026190 - NY N026273 > NY N026190

Previous Ruling Next Ruling
NY N026190




April 24, 2008

CLA-2-30:OT:RR:NC:N2:238

CATEGORY: CLASSIFICATION

TARIFF NO.: 3004.90.9190

Mr. Pradeep Shah
Zydus Pharmaceuticals, USA Inc.
210 Carnegie Center, Suite 103
Princeton, NJ 08540

RE: The tariff classification of Glipizide and Metformin Tablets in 2.5/250 mg, 2.5/500 mg and 5/500 mg imported in dosage form, from India

Dear Mr. Shah:

In your letter dated April , 2008, you requested a tariff classification ruling.

The subject product, Glipizide and Metformin tablets, is a combination of a sulfonylurea hypoglycemic agent (Glipizide) and a biguanide antidiabetic agent (Metformin). It is used for lowering blood sugar levels in combination with diet and exercise in patients with type 2 diabetes.

The applicable subheading for the Glipizide and Metformin tablets in dosage form will be 3004.90.9190, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale: Other: Other: Other: Other." The rate of duty will be free.

Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.

This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).

A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033.

Sincerely,

Robert B. Swierupski
Director,

Previous Ruling Next Ruling

See also: